Addus HomeCare (NASDAQ:ADUS) Stock Rating Lowered by Zacks Investment Research

Addus HomeCare (NASDAQ:ADUSGet Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Monday, Zacks.com reports.

According to Zacks, “ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company’s services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing. “

Several other research firms also recently commented on ADUS. Royal Bank of Canada upped their price objective on shares of Addus HomeCare from $124.00 to $125.00 and gave the company an “outperform” rating in a report on Thursday, March 10th. Bank of America began coverage on shares of Addus HomeCare in a report on Wednesday, April 13th. They set a “buy” rating and a $110.00 price objective on the stock. Finally, StockNews.com started coverage on shares of Addus HomeCare in a report on Thursday, March 31st. They set a “buy” rating on the stock. One research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Addus HomeCare has an average rating of “Buy” and an average price target of $109.00.

Shares of NASDAQ:ADUS traded down $0.10 during trading hours on Monday, hitting $84.18. The company’s stock had a trading volume of 5,108 shares, compared to its average volume of 80,962. Addus HomeCare has a 52 week low of $68.57 and a 52 week high of $110.32. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.76 and a quick ratio of 2.76. The firm has a market capitalization of $1.34 billion, a P/E ratio of 30.06, a price-to-earnings-growth ratio of 2.21 and a beta of 0.84. The company’s fifty day moving average is $83.91.

Addus HomeCare (NASDAQ:ADUSGet Rating) last posted its quarterly earnings data on Thursday, February 24th. The company reported $0.86 EPS for the quarter, missing the consensus estimate of $0.87 by ($0.01). The firm had revenue of $224.64 million for the quarter, compared to the consensus estimate of $226.22 million. Addus HomeCare had a return on equity of 8.97% and a net margin of 5.22%. The company’s revenue was up 14.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.72 EPS. Equities research analysts forecast that Addus HomeCare will post 3.31 EPS for the current year.

In other news, CEO R Dirk Allison sold 1,911 shares of the company’s stock in a transaction on Friday, February 25th. The shares were sold at an average price of $70.57, for a total transaction of $134,859.27. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Brian Poff sold 692 shares of the stock in a transaction dated Friday, February 25th. The shares were sold at an average price of $70.58, for a total transaction of $48,841.36. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,196 shares of company stock valued at $398,605. 4.00% of the stock is owned by insiders.

Several hedge funds have recently made changes to their positions in ADUS. BlackRock Inc. grew its position in Addus HomeCare by 2.6% in the fourth quarter. BlackRock Inc. now owns 2,627,059 shares of the company’s stock valued at $245,655,000 after acquiring an additional 66,485 shares in the last quarter. Capital World Investors lifted its stake in Addus HomeCare by 11.9% during the third quarter. Capital World Investors now owns 938,900 shares of the company’s stock worth $74,877,000 after purchasing an additional 100,000 shares during the last quarter. Silvercrest Asset Management Group LLC lifted its stake in Addus HomeCare by 570.1% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 770,538 shares of the company’s stock worth $71,648,000 after purchasing an additional 655,548 shares during the last quarter. Eaton Vance Management lifted its stake in Addus HomeCare by 3.1% in the fourth quarter. Eaton Vance Management now owns 623,611 shares of the company’s stock valued at $58,263,000 after buying an additional 18,701 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Addus HomeCare by 0.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 549,948 shares of the company’s stock valued at $51,425,000 after buying an additional 4,209 shares during the last quarter. Institutional investors and hedge funds own 96.04% of the company’s stock.

Addus HomeCare Company Profile (Get Rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Get a free copy of the Zacks research report on Addus HomeCare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.